Discusses Topline 48-Week Results From IMPACT Phase IIb Trial of Pemvidutide in MASH December 19, 2025 8:00 AM ...
ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced the U.S. launch of the next generation LifeVest® wearable cardioverter defibrillator (WCD).
Biostatistician Jeffrey Morris discusses his analysis of the vaccine monitoring system — and how it could be improved.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback